The global digestive health supplements market is expected to grow from USD 19.3 billion in 2025 to USD 34.5 billion by 2035, reflecting a CAGR of 6.0% during the forecast period.
This growth is driven by increasing consumer awareness of gut health and the rising demand for natural and preventive health solutions. Digestive health supplements, including probiotics, prebiotics, and digestive enzymes, are being increasingly adopted due to their potential to support digestion, boost immunity, and enhance overall well-being. As lifestyle-related digestive issues become more prevalent, the need for supplements that aid in gut health is also expanding.
| Attributes | Values |
|---|---|
| Market Value (2025) | USD 19.3 Billion |
| Forecast Value (2035) | USD 34.5 Billion |
| CAGR (2025 to 2035) | 6.0% |
In terms of market segmentation, probiotics are expected to dominate the market, accounting for approximately 42% of the market share in 2025. Probiotics, known for their ability to balance gut microbiota, are becoming one of the most sought-after supplements for digestive health.
Their popularity is driven by growing evidence of their positive effects on the immune system and overall digestive health. The Asia Pacific region is identified as the key growth area for the market, with increasing adoption of dietary supplements, improved healthcare access, and rising awareness about preventive health.
A significant development occurred in April 2025, when DSM-Firmenich unveiled its new nutrition supplement innovation platform, Healthy Longevity, at the Vitafoods Europe 2025 trade fair in Barcelona. This platform focuses on advancements in healthy aging and gut health, addressing key areas of well-being.
The launch, set to take place from May 20 to 22, 2025, will feature innovations aimed at tackling cellular senescence, a process where aged cells accumulate and create a pro-inflammatory environment, contributing to age-related conditions.
In March 2025, at the Probiota 2025 conference in Copenhagen, research was presented that highlighted individual microbiome profiles, paving the way for more personalized digestive health solutions. This focus on tailored solutions for diverse gut ecosystems presents a new frontier for the industry
The table below presents a comparative assessment of the variation in CAGR over six months for the base year (2024) and the current year (2025) for the global industry. This analysis reveals crucial shifts in performance and indicates revenue realization patterns, providing stakeholders with a clearer vision of the industry's growth trajectory over the decade.
| Particular | Value CAGR |
|---|---|
| H1 (2024 to 2034) | 5.4% |
| H2 (2024 to 2034) | 6.0% |
| H1 (2025 to 2035) | 5.5% |
| H2 (2025 to 2035) | 6.2% |
The first half of the year (H1) spans from January to June, while the second half (H2) includes the months from July to December. In the first half (H1) of the decade from 2025 to 2035, the industry is projected to grow at a CAGR of 5.4%, followed by a marginally higher growth rate of 6.0% in the second half (H2).
Moving into the subsequent period, from H1 2026 to H2 2035, the CAGR is expected to increase to 5.5% in the first half and maintain a steady 6.2% in the second half. In H1, the sector experienced an increase of 10 BPS, while in H2, the industry recorded a 20 BPS gain, indicating a strong trajectory toward sustained expansion.
Probiotics account for roughly 42% of the global industry share, as increasing consumer awareness about gut microbiome health propels the industry. Popular strains backed by science are Lactobacillus and Bifidobacterium, which are connected to digestion, immunity, and the balance of gut flora. Key brands, including Danone (Activia), Nestlé (Garden of Life), and Procter & Gamble (Align), are expanding with multi-strain formulations tailored to a range of health needs.
Growing cases of constipation, bloating, and acid sulphurization continue to augment the growth of the probiotics industry, along with the robbery of probiotic functional foods and beverages. Additional sales have been contributed via e-commerce that offers clinically validated alternatives. This is supported by sustained investment in probiotic innovation.
Prebiotics constitute an estimated 26% of the global industry, fueled by growing awareness of gut microbiome support and the broader category of digestive wellness. Unlike probiotics, which are the health-promoting microorganisms themselves, prebiotics are non-digestible fibers that ferment in the colon and increase the populations of microorganisms in the gut, assisting the good bacteria.
Industry leaders like BENEO (Orafti Inulin) and Cargill (Fibersol-2), are developing new innovative prebiotic formulations to stimulate fiber consumption and gut health benefits.
With the rising prevalence of gastrointestinal diseases, obesity, and metabolic disorders, consumers are seeking inulin, fructooligosaccharides (FOS), and galactooligosaccharides (GOS) as supplements or through functional foods. The rising prevalence of prebiotic fortified beverages, dairy, and ough foods has contributed to the growing industry penetration of prebiotic ingredients.
Honaletics expects demand for its prebiotic to be high due to increasing research into its use in mental health and immune modulation, said Carlos Vane and Paul Nicolas of the company.
By form type, capsules were the leading segment of the global industry, with a share of almost 38% in overall sales, owing to their high bioavailability, longer shelf life, and convenience in consumption. Some of the top brands in the probiotics and enzymes space like Nature's Bounty, Culturelle, and Renew Life have advanced formula capsules with delayed release and enteric coating for stomach acid survival.
Capsugel (Lonza) and ACG Group created plant-based cellulose capsules that replace gelatine-based alternatives as consumer demand rises for clean-label and vegan options. "Across a spectrum of tailored formulations, we are seeing traction with single-strain and multi-strain probiotics, enzyme complexes, and prebiotic blends.
Likewise, the e-commerce boom and preference for clinically validated, premium supplements continue to drive capsule sales, leading other formats in the digestive health category.
Tablets represent an estimated 29% of the worldwide industry and are seen as an affordable option that provides accurate dosing in a shelf-stable format. Firms, including NOW Foods, Schiff (Digestive Advantage), and Solgar, are developing gummy, fast-melting, and coated tablet formulations to improve flavor and absorption.
The demand for new formulations, particularly in the prebiotics and the enzyme supplements segment, for the effervescents and chewable tablets is expected to rise through 2023 as they are easy to digest and can be eaten on the go. Such alternative products include sugar-free and flavored probiotic tablets from companies like Jamieson and Swisse to appeal to health-conscious consumers.
In the digestive health segment, tablets are a key player-a awareness of the industry top player in several mass-market and drug and pharmacy retail lanes, Fallar opened, which continuous advances in compression technology and bioavailability.
The industry is growing robustly with growing consumer interest in gut health, expanding digestive disorders, and the move toward preventive care. Manufacturers target superior ingredients like probiotics, prebiotics, enzymes, and fiber to formulate effective products under strict regulation. Raw material suppliers focus on consistency and purity to meet the growing demand for natural and organic materials.
Online and offline retailers and distributors focus on product availability, stability of shelf life, and competitive prices to address growing consumer demand. Consumers want supplements that ease digestion problems, promote gut microbiome balance, and facilitate the absorption of nutrients, thereby propelling the trend for clean-label, allergen-free, and clinically tested products.
The trend is also led by plant-based foods, functional foods, and personalized nutrition food and beverages, and digestive health supplements become part of modern wellness routines.
The digestive health supplements business is globally operated at risk affected by the regulatory compliance matters, the raw material supply and industry changes, conflicting producer and consumer interests, and industry competition.
The biggest regulatory challenge is that digestive health supplements are classified as dietary supplements in different parts of the world. Such agencies as USA FDA, EFSA, which works in Europe, and FSSAI in India give out stringent requirements regarding ingredient safety, labeling, health claims, and clinical evidence. Non-compliance can cause the products involved to be recalled, penalties imposed, as well as damage to the manufacturer's reputation.
The raw material availability is somewhat related to discarding due to probiotics, prebiotics, digestive enzymes, and fiber compounds being the main components of digestive supplements. Disruptions in the supply chain, agricultural production, and climate change can all lead to the extent of fluctuation of prices and the sources that are at risk of being exhausted.
The consumers' interests firstly evolve towards more natural, organic, and plant-based supplements. The brands insisting on innovation or changing formulations based on trending topics, i.e. the gut microbiome field and personalized nutrition, shall be in a serious danger of industry massacre.
The price of raw materials is a key contributor to product costs, and supply chain problems can complicate the situation. Distributing low transportation costs, ingredient elapses, and barriers to international trade can impact the stocks, thus initiating delays in the delivery and higher costs.
The industry area is indeed highly competitive with both the well-known companies and new enterprises gaining industry share with the right drugs, branding, and formulation innovation. Newer companies highlighted on the specific data of clinical validation, sustainability, or unique formulations are more likely to do well in today`s growing global industry while the old ones that seem to maintain their original products would lose success.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 6.5% |
| China | 7.9% |
| India | 4.5% |
| Japan | 3.8% |
The USA is a leader in the global industry for digestive health supplements, with a forecasted CAGR of 6.5% from 2025 to 2035. Increasing consumer understanding of gut health and its role in well-being has contributed to industry expansion.
The rising prevalence of digestive disorders like irritable bowel syndrome and gastroesophageal reflux disease has increased the demand for probiotics, prebiotics, and enzyme-based supplements. Product development and delivery innovations continue to attract health-conscious customers.
Expanding e-commerce platforms have also increased accessibility, making these supplements more widely available. The presence of industry participants and positive regulatory conditions support industry growth. FMI believes that the USA industry is set to grow at 5.4% CAGR during the research period.
Growth Drivers in the USA
| Key Drivers | Details |
|---|---|
| Growing Consumer Awareness | More consumers recognize the value of gut health to overall wellness. |
| Higher Incidence of Digestive Disorders | More consumers seek out probiotics and enzyme-based supplements. |
| Product Innovation | Better formulations and innovative delivery systems enhance efficacy. |
| More Online Shopping | Online platforms increase convenience and accessibility. |
The Chinese industry is growing fast and is anticipated to reach a CAGR of 7.9% in the forecast period of 2025 to 2035. Growing health awareness and the rising prevalence of digestive disorders due to urbanization fuel growth. Consumers are looking for herbal and natural supplements which align with traditional Chinese medicine practices.
Government support for the health supplement industry and aggressive growth in high-speed online distribution channels have also boosted product availability. Local players continue R&D expenditure to launch new products, and international brands are making an entry through strategic alliances. Increasing the disposable incomes of China's growing middle class further supports the increase in industry growth.
Growth Drivers in China
| Key Drivers | Details |
|---|---|
| Transition to Natural Supplements | Traditional Chinese medicine influences consumer behavior. |
| Government Policies | Policy initiatives strengthen the health supplement industry. |
| E-commerce Expansion | Online platforms increase the availability of digestive supplements. |
| Emerging Middle-Class Demand | Rising disposable incomes encourage supplement purchases. |
Food culture, urban life, and a rise in gastrointestinal diseases have boosted demand for digestive health products. Prebiotics and probiotics are finding their way into everyday diets by consumers because they are believed to provide several health advantages. Ayurveda drives industry demand, and high-end demand is present for natural and herbal supplements.
Incentives by the government for wellness and preventive care and the growth of the nutraceuticals business have given healthy industry conditions to grow. Increased accessibility through digital channels makes the products available to urban and rural customers.
FMI considers the Indian industry to grow at 4.5% CAGR over the study period.
Growth Drivers in India
| Key Drivers | Details |
|---|---|
| Increasing Health Consciousness | Shoppers adopt digestive supplements for better well-being. |
| Ayurvedic Influence | Traditional medicine boosts the demand for herbal supplements. |
| Government Health Campaigns | Preventive healthcare programs encourage supplement adoption. |
| E-commerce Development | Online platforms widen industry reach. |
There is a high demand for quality, evidence-based digestive health products, especially from age groups. Probiotic, prebiotic, and enzyme-rich functional foods are tolerated as a part of a normal diet.
Japan's dependence on imports of digestive health supplements from the USA and EU has helped to give its industry a premium character. R&D in domestic companies focused on enhanced probiotic functionality and bioavailability of supplements. Growth in specialty health store outlets and pharmacy-based retailing of supplements also supports industry growth.
According to FMI. The Japanese industry for digestive health supplements is anticipated to register a 3.8% CAGR during the forecast period.
Growth Drivers in Japan
| Key Drivers | Details |
|---|---|
| Aging Population | Older consumers prioritize digestive health. |
| Scientific Research in Probiotics | R&D enhances the bioavailability and efficacy of probiotics. |
| Premium Supplement Industry | Japan imports high-quality digestive supplements. |
| Growing Health Retail Chains | Pharmacy-led distribution increases availability. |
The digestive health supplements market is characterized by a competitive landscape, featuring dominant players, key players, and emerging firms. Dominant players such as Bayer AG, Abbott, and Glanbia plc hold leading positions, supported by their extensive product portfolios, global distribution networks, and well-known brands like Iberogast and Align.
Key players including Herbalife Nutrition Ltd., Nature’s Bounty, and Amway Corporation focus on diverse supplement offerings, from probiotics to digestive enzymes, with strong regional presences in North America and Europe.
Emerging players like Seed Health, Zenwise, and Alimentary Health Limited are gaining traction by catering to the growing demand for specialized, science-backed, and plant-based digestive health solutions, offering innovative products in the evolving market.
Recent Digestive Health Supplements Industry News
By product type, the industry is segmented into prebiotics, probiotics, enzymes, and others.
By form, the industry is segmented into capsules, tablets, powder, and others.
By distribution channel, the industry is segmented into offline channel and online channel.
By region, the industry is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.
The industry is slated to reach USD 19.3 billion in 2025.
The industry is predicted to reach a size of USD 34.5 billion by 2035.
Key companies include Amway Corp, Bayer AG, Pfizer Inc., DSM N.V., Lonza Group Ltd., The Bountiful Company, NOW Foods, Herbalife Nutrition Ltd., Alimentary Health Limited, and Nestlé Health Science.
China, slated to grow at 7.9% CAGR during the forecast period, is poised for the fastest growth.
Probiotics are being widely used.
Explore Food Supplement and Nutrition Insights
Digestive Health Supplements Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
